3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
330786-24-8,
4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine,
Ibrutinib N-2,
AK161694,
A1-02187,
C17H13N5O,
1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(4-phenoxyphenyl)-,
SCHEMBL200349,
CHEMBL1242204,
YYVUOZULIDAKRN-UHFFFAOYSA-N,
BCP08092,
CS-M2418,
KS-00000A8A,
3209AH,
ABP001124,
MFCD20270360,
ZINC64527573,
AKOS024464512,
AKOS032949962,
CM11014,
DS-7365,
TRA0052080,
SC-01281,
SY032999,
AJ-114864,
AX8273860,
FT-0696694,
ST24041497,
MFCD20270360 (97%),
4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyri,
Z2753057767,
4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine; 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
ACN-028783,
5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine,
3-(3-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,